Vaccines and Related Biological Products Advisory Committee
November 14, 2007
Date and Time:
The meeting will be held by teleconference on November 14, 2007 from 1:00 pm to approximately 4:30 pm.
Location:
National Institutes of Health, Building 29B, Conference Rooms A/B, Bethesda, MD. This meeting will be held by teleconference. The public is welcome to attend the meeting at the specified location where a speakerphone will be provided.
Contact Persons:
Christine Walsh or Denise Royster, Center for Biologics Evaluation and Research (HFM-71), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512391. Please call the Information Line for up-to-date information on this meeting.
Agenda:
On November 14, 2007, the Committee will meet in open session to hear updates of the research programs in (1) The Laboratory of Method Development, Division of Viral Products, Center for Biologics Evaluation and Research, FDA and (2) The Laboratory of Mycobacterial Diseases & Cellular Immunology, Division of Bacterial Parasitic & Allergenic Products, Center for Biologics Evaluation and Research, FDA.
Oral Presentations:
Oral presentations from the public will be scheduled between approximately 2:30 pm and 3:30 pm. Those desiring to make formal oral presentations should notify the contact person on or before October 30, 2007.
Closed Committee Deliberations:
On November 14, 2007 from approximately 3:30 pm to 4:30 pm, the meeting will be closed to permit discussion where disclosure would constitute a clearly unwarranted invasion of personal privacy (5 U.S.C. 552b(c)(6)). The Committee will discuss reports of intramural research programs and make recommendations regarding personnel staffing decisions.